Eunice S. Wang MD
Eunice S. Wang
MD
Associate Professor of Medicine
Jacobs School of Medicine & Biomedical Sciences
Specialty/Research Focus
Hematology; Immunology; Internal Medicine - General
Education and Training:
- Fellowship, Hematology Oncology, Memorial Sloan Kettering Cancer Institute (2003)
- Residency, Internal Medicine, Yale-New Haven Hospital (1999)
- MD, Medicine, Keck (University of Southern California) School of Medicine (1996)
- Biological Sciences, Harvard-Radcliffe Colleges, Harvard University, Cum Laude (1991)
Employment:
- Associate Professor, Medicine, Roswell Park Comprehensive Cancer Center Jacobs School of Medicine & Biomedical Sciences (2016-present)
- Associate Director, Hematology-Oncology Fellowship Program, SUNY-UB School of Medicine and Biomedical Sciences, Buffalo, NY (2012-present)
- Staff Attending Physician, Sisters Hospital / Catholic Health Systems, Dpt of Medicine, Dpt of Medicine, Sisters Hospital / Catholic Health Systems (2012-present)
- Staff Attending Physician, Dpt of Medicine, Dpt of Medicine, Kaleida Health Services/Buffalo General Hospital, Dpt of Medicine (2011-present)
- Member, New York State Center of Excellence, New York State Center of Excellence, New York State Center of Excellence, SUNY-UB School of Medicine and Biomedical Sciences New York State Center of Excellence, SUNY-UB School of Medicine and Biomedical Sciences (2009-present)
- Assistant Member, Roswell Park Cancer Institute - Department of Tumor Immunology (2003-present)
- Associate Professor of Oncology, Medicine, Roswell Park Cancer Institute (2003-present)
- Member, Graduate Faculty Program, SUNY-UB School of medicine and Biomedical Sciences and Roswell Park Cancer Institute, SUNY-UB School of Medicine and Biomedical Sciences and Roswell Park Cancer Institute SUNY-UB School of Medicine and Biomedical Sciences and Roswell Park Cancer Institute (2003-present)
- Research Assistant Professor, Medicine, SUNY-UB School of Medicine and Biomedical Sciences Jacobs School of Medicine & Biomedical Sciences (2003-present)
- Staff Attending Physician, Leukemia Service, Dpt of Medicine, Leukemia Service, Dpt of Medicine, Roswell Park Cancer Institute (2003-present)
Awards and Honors:
- Best Teaching Attending Award, UB / RPCI Hematology-Oncology Fellowship Program (2013)
- NCI Cancer Clinical Investigator Team Leadership Award (2013)
- Buffalo Business Frist Health Care 50 (2012)
- Stewardship Stars Award, RPCI Alliance Foundation (2011)
- American Cancer Society Mentored Research Scholar (2010)
- Leukemia Lymphoma Society Patient Service Award (2007)
- Participant, AACR/ASCO Workship: Methods in Clinical Cancer Research (2004)
- Participant, AACR Workship: Molecular Biology in Clinical Oncology (2003)
- American Society of Clnical Oncology Young Investigator Award (2003)
- Clinical Scholars Training Fellowship / Revson Foundation Fellow in Biomedical Research (2003)
- Doris Duke "Bench to Bedside" Translational Research Award (2002)
- American Society of Hematology Travel Award (2002)
- GlaxoSmith Kline National Medical Oncology Fellows' Forum Platform Presentation (2002)
- Medical Student Research Fellowship, University of Southern California School of Medicine (1993)
- Harvard University-Magna cum laude senior undergraduate research thesis (1991)
- Harvard College Scholarship (1989)
- Elizabeth Cary Agassiz Certificate of Merit (1989)
Grants and Sponsored Research:
- January 2007–January 2012
Clinical application of multispectral imaging flow cytometry
NIH
Role: Co-Investigator - January 2009
Multi-dimensional genomic studies of MLL leukemia
Role: Co-Investigator
Journal Articles:
- Sharma S, Wang J, Alqassim E, Portwood S, Cortes Gomez E, Maguire O, Basse PH, Wang ES, Segal BH, Baysal BE. (2019) Mitochondrial hypoxic stress induces widespread RNA editing by APOBEC3G in natural killer cells. Genome Biol (Jan), 20(1): 37-37.
- Przespolewski A, Szeles A, Wang ES, Przespolewski AC. (2018) Advances in immunotherapy for acute myeloid leukemia. Future Oncol (Mar).
- Przespolewski AC, Szeles A, Elshoury E, Wang ES. (2017) Chimeric Antigen Receptor T-Cell Therapy in Acute Myeloid Leukemia. Journal of Targeted Therapies (Oct).
- Przespolewski A, Wang ES, Przespolewski AC. (2016) Inhibitors of LSD1 as a potential therapy for acute myeloid leukemia. Expert Opin Investig Drugs (Jul), 25(7): 771-780.
- Almyroudis NG, Osawa R, Samonis G, Wetzler M, Wang ES, McCarthy PL, Segal BH. (2016) Discontinuation of Systematic Surveillance and Contact Precautions for Vancomycin-Resistant Enterococcus (VRE) and Its Impact on the Incidence of VRE faecium Bacteremia in Patients with Hematologic Malignancies. Infect Control Hosp Epidemiol (Apr), 37(4): 398-403.
- Freyer CW, Gupta N, Wetzler M, Wang ES. (2014) Revisiting the Role of Cladribine in Acute Myeloid Leukemia: An Improvement on Past Accomplishments or More Old News?. Am J Hematol (Oct).
- Chen GL, Liu H, Zhang Y, Thomas J, Ross M, Wang ES, Block AW, Sait S, Deeb G, Wallace P, Wetzler M, Hahn T, McCarthy PL. (2014) Early versus late preemptive allogeneic hematopoietic cell transplantation for relapsed or refractory acute myeloid leukemia. Biol Blood Marrow Transplant (Sep), 20(9): 1369-1374.
- Smith MB, Griffiths EA, Thompson JE, Wang ES, Wetzler M, Freyer CW. (2014) High pseudotumor cerebri incidence in tretinoin and arsenic treated acute promyelocytic leukemia and the role of topiramate after acetazolamide failure. Leuk Res Rep (Jul), 3(2): 62-66.
- Prebet T, Sun Z, Figueroa ME, Ketterling R, Melnick A, Greenberg PL, Herman J, Juckett M, Smith MR, Malick L, Paietta E, Czader M, Litzow M, Gabrilove J, Erba HP, Gore SD, Tallman MS, Wang ES. (2014) Prolonged administration of azacitidine with or without entinostat for myelodysplastic syndrome and acute myeloid leukemia with myelodysplasia-related changes: results of the US Leukemia Intergroup trial E1905. J Clin Oncol (Apr), 32(12): 1242-1248.
- Yee KW, Storring JM, Buckstein R, Wells RA, Xenocostas A, Kovacs MJ, Howson-Jan K, Wang ES, Battista K, Wang L, Oza AM, Ivy SP, Schuh AC. (2014) Sunitinib malate in patients with intermediate-2 or high-risk myelodysplastic syndrome or chronic myelomonocytic leukemia. Leuk Lymphoma (Apr).
- Gupta N, Wang ES. (2014) Long-term response of refractory primary cold agglutinin disease to eculizumab therapy. Ann Hematol (Feb), 93(2): 343-344.
- Lee HJ, Muindi JR, Tan W, Hu Q, Wang D, Liu S, Wilding GE, Ford LA, Sait SN, Block AW, Adjei AA, Barcos M, Griffiths EA, Thompson JE, Wang ES, Johnson CS, Trump DL, Wetzler M. (2014) Low 25(OH) vitamin D3 levels are associated with adverse outcome in newly diagnosed, intensively treated adult acute myeloid leukemia. Cancer (Feb), 120(4): 521-529.
- Deeb G, Wang E, Wallace P, Wang ES. (2014) Case study interpretation-Fort Lauderdale: Case 3. Cytometry B Clin Cytom (Feb).
- Deeb G, Wang E, Wallace P, Wang ES. (2013) Case Study Interpretation-Fort Lauderdale: Case 3. Cytometry B Clin Cytom (Dec).
- Portwood S, Lal D, Hsu YC, Vargas R, Johnson MK, Wetzler M, Hart CP, Wang ES. (2013) Activity of the hypoxia-activated prodrug, TH-302, in preclinical human acute myeloid leukemia models. Clin Cancer Res (Dec), 19(23): 6506-6519.
- Vigil CE, Tan W, Deeb G, Sait SN, Block AW, Starostik P, Griffiths EA, Thompson JE, Greene JD, Ford LA, Wang ES, Wetzler M. (2013) Phase II trial of clofarabine and daunorubicin as induction therapy for acute myeloid leukemia patients greater than or equal to 60 years of age. Leuk Res (Nov), 37(11): 1468-1471.
- O'Donnell MR, Tallman MS, Abboud CN, Altman JK, Appelbaum FR, Arber DA, Attar E, Borate U, Coutre SE, Damon LE, Lancet J, Maness LJ, Marcucci G, Martin MG, Millenson MM, Moore JO, Ravandi F, Shami PJ, Smith BD, Stone RM, Strickland SA, Wang ES, Gregory KM, Naganuma M. (2013) Acute myeloid leukemia, version 2.2013. J Natl Compr Canc Netw (Sep), 11(9): 1047-1055.
- Wetzler M, Thomas DA, Wang ES, Shepard R, Ford LA, Heffner TL, Parekh S, Andreeff M, O'Brien S, Kantarjian HM. (2013) Phase I/II trial of nanomolecular liposomal annamycin in adult patients with relapsed/refractory acute lymphoblastic leukemia. Clin Lymphoma Myeloma Leuk (Aug), 13(4): 430-434.
- Al Ustwani O, Ford LA, Sait SJ, Block AM, Barcos M, Vigil CE, Griffiths EA, Thompson JE, Wang ES, Ambrus J, Wetzler M. (2013) Myelodysplastic syndromes and autoimmune diseases--case series and review of literature. Leuk Res (Aug), 37(8): 894-899.
- Francis J, Dharmadhikari AV, Sait SN, Deeb G, Wallace PK, Thompson JE, Wang ES, Wetzler M. (2013) CD19 expression in acute leukemia is not restricted to the cytogenetically aberrant populations. Leuk Lymphoma (Jul), 54(7): 1517-1520.
- Garvin JH, Elkin PL, Shen S, Brown S, Trusko B, Wang E, Hoke L, Quiaoit Y, Lajoie J, Weiner MG, Graham P, Speroff T. (2013) Automated quality measurement in department of the veterans affairs discharge instructions for patients with congestive heart failure. J Healthc Qual (Jul), 35(4): 16-24.
- Brady MT, Miller A, Sait SN, Ford LA, Minderman H, Wang ES, Lee KP, Baumann H, Wetzler M. (2013) Down-regulation of signal transducer and activator of transcription 3 improves human acute myeloid leukemia-derived dendritic cell function. Leuk Res (Jul), 37(7): 822-828.
- Fetterly GJ, Aras U, Lal D, Murphy M, Meholick PD, Wang ES. (2013) Development of a preclinical PK/PD model to assess antitumor response of a sequential aflibercept and doxorubicin-dosing strategy in acute myeloid leukemia. AAPS J (Jul), 15(3): 662-673.
- Attar EC, Johnson JL, Amrein PC, Lozanski G, Wadleigh M, DeAngelo DJ, Kolitz JE, Powell BL, Voorhees P, Wang ES, Blum W, Stone RM, Marcucci G, Bloomfield CD, Moser B, Larson RA. (2013) Bortezomib added to daunorubicin and cytarabine during induction therapy and to intermediate-dose cytarabine for consolidation in patients with previously untreated acute myeloid leukemia age 60 to 75 years: CALGB (Alliance) study 10502. J Clin Oncol (Mar), 31(7): 923-929.
- Wang ES, Lyons RM, Larson RA, Gandhi S, Liu D, Matei C, Scott B, Hu K, Yang AS. (2012) A randomized, double-blind, placebo-controlled phase 2 study evaluating the efficacy and safety of romiplostim treatment of patients with low or intermediate-1 risk myelodysplastic syndrome receiving lenalidomide. J Hematol Oncol (Nov), 5: 71-71.
- Minderman H, Humphrey K, Arcadi JK, Wierzbicki A, Maguire O, Wang ES, Block AW, Sait SN, George TC, Wallace PK. (2012) Image cytometry-based detection of aneuploidy by fluorescence in situ hybridization in suspension. Cytometry A (Sep), 81(9): 776-784.
- O'Donnell MR, Abboud CN, Altman J, Appelbaum FR, Arber DA, Attar E, Borate U, Coutre SE, Damon LE, Goorha S, Lancet J, Maness LJ, Marcucci G, Millenson MM, Moore JO, Ravandi F, Shami PJ, Smith BD, Stone RM, Strickland SA, Tallman MS, Wang ES, Naganuma M, Gregory KM. (2012) Acute myeloid leukemia. J Natl Compr Canc Netw (Aug), 10(8): 984-1021.
- Wang ES, Yee K, Koh LP, Hogge D, Enschede S, Carlson DM, Dudley M, Glaser K, McKeegan E, Albert DH, Li X, Pradhan R, Stock W. (2012) Phase 1 trial of linifanib (ABT-869) in patients with refractory or relapsed acute myeloid leukemia. Leuk Lymphoma (Aug), 53(8): 1543-1551.
- Faderl S, Wetzler M, Rizzieri D, Schiller G, Jagasia M, Stuart R, Ganguly S, Avigan D, Craig M, Collins R, Maris M, Kovacsovics T, Goldberg S, Seiter K, Hari P, Greiner J, Vey N, Recher C, Ravandi F, Wang ES, Vasconcelles M, Huebner D, Kantarjian HM. (2012) Clofarabine plus cytarabine compared with cytarabine alone in older patients with relapsed or refractory acute myelogenous leukemia: results from the CLASSIC I Trial. J Clin Oncol (Jul), 30(20): 2492-2499.
- Jarkowski A, Forrest A, Sweeney RP, Tan W, Segal BH, Almyroudis N, Wang ES, Wetzler M. (2012) Characterization of vancomycin pharmacokinetics in the adult acute myeloid leukemia population. J Oncol Pharm Pract (Mar), 18(1): 91-96.
- Lee HJ, Licht AS, Hyland AJ, Ford LA, Sait SN, Block AW, Barcos M, Baer MR, Wang ES, Wetzler M. (2012) Is obesity a prognostic factor for acute myeloid leukemia outcome?. Ann Hematol (Mar), 91(3): 359-365.
- Varadarajan R, Licht AS, Hyland AJ, Ford LA, Sait SN, Block AW, Barcos M, Baer MR, Wang ES, Wetzler M. (2012) Smoking adversely affects survival in acute myeloid leukemia patients. Int J Cancer (Mar), 130(6): 1451-1458.
- Garvin JH, Elkin PL, Shen S, Brown S, Trusko B, Wang E, Hoke L, Quiaoit Y, Lajoie J, Weiner MG, Graham P, Speroff T. (2012) Automated Quality Measurement in Department of the Veterans Affairs Discharge Instructions for Patients with Congestive Heart Failure. J Healthc Qual (Jan).
- Wetzler M, Andrews C, Ford LA, Tighe S, Barcos M, Sait SN, Block AW, Nowak NJ, Baer MR, Wang ES, Baumann H. (2011) Phase 1 study of arsenic trioxide, high-dose cytarabine, and idarubicin to down-regulate constitutive signal transducer and activator of transcription 3 activity in patients aged <60 years with acute myeloid leukemia. Cancer (Nov), 117(21): 4861-4868.
- Noor SJ, Tan W, Wilding GE, Ford LA, Barcos M, Sait SN, Block AW, Thompson JE, Wang ES, Wetzler M. (2011) Myeloid blastic transformation of myeloproliferative neoplasms--a review of 112 cases. Leuk Res (May), 35(5): 608-613.
- Deeb G, Vaughan MM, McInnis I, Ford LA, Sait SN, Starostik P, Wetzler M, Mashtare T, Wang ES. (2011) Hypoxia-inducible factor-1a protein expression is associated with poor survival in normal karyotype adult acute myeloid leukemia. Leuk Res (May), 35(5): 579-584.
- Vigil CE, Griffiths EA, Wang ES, Wetzler M. (2011) Interpretation of cytogenetic and molecular results in patients treated for CML. Blood Rev (May), 25(3): 139-146.
- Lee HJ, Thompson JE, Wang ES, Wetzler M. (2011) Philadelphia chromosome-positive acute lymphoblastic leukemia: current treatment and future perspectives. Cancer (Apr), 117(8): 1583-1594.
- Levis M, Ravandi F, Wang ES, Baer MR, Perl A, Coutre S, Erba H, Stuart RK, Baccarani M, Cripe LD, Tallman MS, Meloni G, Godley LA, Langston AA, Amadori S, Lewis ID, Nagler A, Stone R, Yee K, Advani A, Douer D, Wiktor-Jedrzejczak W, Juliusson G, Litzow MR, Petersdorf S, Sanz M, Kantarjian HM, Sato T, Tremmel L, Bensen-Kennedy DM, Small D, Smith BD. (2011) Results from a randomized trial of salvage chemotherapy followed by lestaurtinib for patients with FLT3 mutant AML in first relapse. Blood (Mar), 117(12): 3294-3301.
- O'Donnell MR, Abboud CN, Altman J, Appelbaum FR, Coutre SE, Damon LE, Foran JM, Goorha S, Maness LJ, Marcucci G, Maslak P, Millenson MM, Moore JO, Ravandi F, Shami PJ, Smith BD, Stone RM, Strickland SA, Tallman MS, Wang ES. (2011) Acute myeloid leukemia. J Natl Compr Canc Netw (Mar), 9(3): 280-317.
- Brady MT, Lee J, Ferrone S, Wang ES, Wetzler M. (2011) Interferon-? secretion by t(9;22) acute lymphoblastic leukemia-derived dendritic cells. Leuk Res (Feb), 35(2): 275-277.
- Saranadasa M, Wang ES. (2011) Vascular endothelial growth factor inhibition: conflicting roles in tumor growth. Cytokine (Feb), 53(2): 115-129.
- Kantarjian HM, Giles FJ, Greenberg PL, Paquette RL, Wang ES, Gabrilove JL, Garcia-Manero G, Hu K, Franklin JL, Berger DP. (2010) Phase 2 study of romiplostim in patients with low- or intermediate-risk myelodysplastic syndrome receiving azacitidine therapy. Blood (Oct), 116(17): 3163-3170.
- Wang ES, Sait SN, Gold D, Mashtare T, Starostik P, Ford LA, Wetzler M, Nowak NJ, Deeb G, Wang E. (2010) Genomic, immunophenotypic, and NPM1/FLT3 mutational studies on 17 patients with normal karyotype acute myeloid leukemia (AML) followed by aberrant karyotype AML at relapse. Cancer Genet Cytogenet (Oct), 202(2): 101-107.
- Lal D, Park JA, Demock K, Marinaro J, Perez AM, Lin MH, Tian L, Mashtare TJ, Murphy M, Prey J, Wetzler M, Fetterly GJ, Wang ES. (2010) Aflibercept exerts antivascular effects and enhances levels of anthracycline chemotherapy in vivo in human acute myeloid leukemia models. Mol Cancer Ther (Oct), 9(10): 2737-2751.
- Varadarajan R, Cummings MK, Hyland AJ, Wang ES, Wetzler M. (2010) Can decreasing smoking prevalence reduce leukemia mortality?. Ann Hematol (Sep), 89(9): 873-876.
- Ngamphaiboon N, Sweeney R, Wetzler M, Wang ES. (2010) Pyridoxine treatment of vincristine-induced cranial polyneuropathy in an adult patient with acute lymphocytic leukemia: Case report and review of the literature. Leuk Res (Aug), 34(8): 194-196.
- Nowak NJ, Sait SN, Zeidan A, Deeb G, Gaile D, Liu S, Ford L, Wallace PK, Wang ES, Wetzler M. (2010) Recurrent deletion of 9q34 in adult normal karyotype precursor B-cell acute lymphoblastic leukemia. Cancer Genet Cytogenet (May), 199(1): 15-20.
- Varadarajan R, Ford L, Sait SN, Block AW, Barcos M, Wallace PK, Ramnath N, Wang ES, Wetzler M. (2009) Metachronous and synchronous presentation of acute myeloid leukemia and lung cancer. Leuk Res (Sep), 33(9): 1208-1211.
- Harb AJ, Tan W, Wilding GE, Ford L, Sait SN, Block AW, Barcos M, Wallace PK, Wang ES, Wetzler M. (2009) Treating octogenarian and nonagenarian acute myeloid leukemia patients--predictive prognostic models. Cancer (Jun), 115(11): 2472-2481.
- Harb A, Tan W, Wilding GE, Battiwalla M, Sait SN, Wang ES, Wetzler M. (2009) Acute myeloid leukemia and diabetes insipidus with monosomy 7. Cancer Genet Cytogenet (Apr), 190(2): 97-100.
- Drake AS, Brady MT, Wang XH, Sait SJ, Earp JC, Ghoshal Gupta S, Ferrone S, Wang ES, Wetzler M. (2009) Targeting 11q23 positive acute leukemia cells with high molecular weight-melanoma associated antigen-specific monoclonal antibodies. Cancer Immunol Immunother (Mar), 58(3): 415-427.
- Zeidan A, Wang ES, Wetzler M. (2009) Pegasparaginase: where do we stand?. Expert Opin Biol Ther (Jan), 9(1): 111-119.
- Zeidan A, Wang ES, Wetzler M. (2008) What is imatinib-resistant chronic myeloid leukemia? Identifying and managing loss of response. Clin Adv Hematol Oncol (Sep), 6(9): 673-683.
- Shivakumar R, Tan W, Wilding GE, Wang ES, Wetzler M. (2008) Biologic features and treatment outcome of secondary acute lymphoblastic leukemia--a review of 101 cases. Ann Oncol (Sep), 19(9): 1634-1638.
- Abdelhalim A, Barcos M, Block AW, Sait SN, Starostik P, Wetzler M, Wang ES. (2007) Remission of Philadelphia chromosome-positive central nervous system leukemia after dasatinib therapy. Leuk Lymphoma (May), 48(5): 1053-1056.
- Wang ES, Teruya-Feldstein J, Wu Y, Zhu Z, Hicklin DJ, Moore MA. (2004) Targeting autocrine and paracrine VEGF receptor pathways inhibits human lymphoma xenografts in vivo. Blood (Nov), 104(9): 2893-2902.
- Wang EQ, Fung HL. (2004) Prazosin potentiates the acute hypotensive effects of nitroglycerin but does not attenuate nitrate tolerance in normal conscious rats. J Cardiovasc Pharmacol (Mar), 43(3): 341-346.
- Wang EQ, Balthasar JP, Fung HL. (2004) Pharmacodynamics of in vivo nitroglycerin tolerance in normal conscious rats: effects of dose and dosing protocol. Pharm Res (Jan), 21(1): 114-120.
- Wang ES, Wu K, Chin AC, Chen-Kiang S, Pongracz K, Gryaznov S, Moore MA. (2004) Telomerase inhibition with an oligonucleotide telomerase template antagonist: in vitro and in vivo studies in multiple myeloma and lymphoma. Blood (Jan), 103(1): 258-266.
- Wang ES, Straus DJ, Teruya-Feldstein J, Qin J, Portlock C, Moskowitz C, Goy A, Hedrick E, Zelenetz AD, Noy A. (2003) Intensive chemotherapy with cyclophosphamide, doxorubicin, high-dose methotrexate/ifosfamide, etoposide, and high-dose cytarabine (CODOX-M/IVAC) for human immunodeficiency virus-associated Burkitt lymphoma. Cancer (Sep), 98(6): 1196-1205.
- Wang ES, O'Connor O, She Y, Zelenetz AD, Sirotnak FM, Moore MA. (2003) Activity of a novel anti-folate (PDX, 10-propargyl 10-deazaaminopterin) against human lymphoma is superior to methotrexate and correlates with tumor RFC-1 gene expression. Leuk Lymphoma (Jun), 44(6): 1027-1035.
- Brazeau DA, Wang E, Fung HL, Lee, W.-I. (2002) cDNA Microarray Analysis of Vascular Gene Expression After Nitric Oxide Donor Infusions in Rats: Implications for Nitrate Tolerance Mechanisms. AAPS PharmSci 2002 (Jan), 4(2): 10.
- Wang EQ, Fung HL. (2002) Effects of obesity on the pharmacodynamics of nitroglycerin in conscious rats. AAPS PharmSci (Jan), 4(4): 28-28.
- Wang EQ, Lee WI, Fung HL. (2002) Lack of critical involvement of endothelial nitric oxide synthase in vascular nitrate tolerance in mice. Br J Pharmacol (Jan), 135(2): 299-302.
- Wang EQ, Soda DM, Fung HL. (2001) Nitroglycerin-induced relaxation of anorectal smooth muscle: evidence for apparent lack of tolerance development in the anaesthetized rat. Br J Pharmacol (Sep), 134(2): 418-424.
- Wang ES, Maslak P, Cathcart K, Jurcic JG. (2001) Acute myeloid leukemia with t(5;18)(q35;q21). Cancer Genet Cytogenet (May), 127(1): 71-73.
Abstracts:
- Wojtaszczyk JA, Hahn T, Battiwalla M, Baer MR, Wang ES, Barcos MP, Bambach BJ, Padmanabhan S, Wetzler M, McCarthy PL. (2006) Effect of Bone Marrow Hypoplasia Secondary to Reinduction Therapy for Acute Myeloid Leukemia (AML) or Myelodysplastic Syndrome (MDS) on Outcomes after Blood and Marrow Transplantation (BMT). Blood, (Nov) 3033-3033
Professional Memberships:
- Society of Hematologic Oncology (SOHO) (2013–present)
- American Association of Internal Medicine (AAIM) (2012–present)
- American Society of Clinical Oncology (ASCO) (1999–present)
- American Society of Hematology (ASH) (1999–present)
- American Association of Cancer Research (AACR) (1999–present)
Presentations:
- "Treatment of AML in the Older Adult" American Society of Hematology Annual Meeting, San Francisco, California; American Society of Hematology Annual Meeting, San Francisco, California; American Society of Hematology Annual Meeting, San Francisco, California (2014)
- "AML: Current Management" National Comprehensive Cancer Network (NCCN); National Comprehensive Cancer Network (NCCN); National Comprehensive Cancer Network (NCCN) (2014)
- Faculty Speaker, Scientific Retreat; Roswell Park Cancer Institute; Faculty Speaker, Scientific Retreat (2014)
- WCA Hospital Grand Rounds; WCA Hospital; Grand Rounds (2014)
- VA Medical Center Grand Rounds; VA; Grand Rounds (2014)
- Dept Hematology, Hematology seminar, Yale Cancer Center, New Haven, NY; Dept Hematology, Hematology seminar, Yale Cancer Center, New Haven, NY; Dept Hematology, Hematology seminar, Yale Cancer Center, New Haven, NY (2014)
- Chemotherapy Seminar Series, Pharmacology & Therapeutics, RPCI; Chemotherapy Seminar Series, Pharmacology & Therapeutics, RPCI; Chemotherapy Seminar Series, Pharmacology & Therapeutics, RPCI (2013)
- Buffalo General Hospital Medical Grand Rounds; Buffalo General Hospital; Medical Grand Rounds (2013)
- "Targeting the marrow microenvironment in acute leukemia" Hematology Grand Rounds, Department of Medicine, Vanderbilt-‐Ingram; Hematology Grand Rounds, Department of Medicine, Vanderbilt-‐Ingram; Hematology Grand Rounds, Department of Medicine, Vanderbilt-‐Ingram (2013)
- 6th Annual Houston Conference for Myelodysplastic Syndromes &; 6th Annual Houston Conference for Myelodysplastic Syndromes &; 6th Annual Houston Conference for Myelodysplastic Syndromes & (2011)
- Hematology -Oncology Grand Rounds, University of Wisconsin, Madison - Dpt of Medicine; Hematology -Oncology Grand Rounds, University of Wisconsin, Madison - Dpt of Medicine; Hematology -Oncology Grand Rounds, University of Wisconsin, Madison - Dpt of Medicine (2010)
- Medical Grand Rounds, Wilmot Cancer Center, Rochester, NY; Medical Grand Rounds, Wilmot Cancer Center, Rochester, NY; Medical Grand Rounds, Wilmot Cancer Center, Rochester, NY (2009)
- Dept Oral Biology Seminar Series, UB Dental School,; UB Dental School; Dept Oral Biology Seminar Series, UB Dental School, (2007)
- National: Enzon Pharmaceuticals; Enzon Pharmaceuticals; Enzon Pharmaceuticals (2006)
- Molecular and Developmental Genetics Seminar, RPCI,; Roswell Park Cancer Institute; Molecular and Developmental Genetics Seminar, RPCI, (2006)
- National Marrow Donor Program: Clinical Guidelines for Transplantation,; National Marrow Donor Program: Clinical Guidelines for Transplantation,; National Marrow Donor Program: Clinical Guidelines for Transplantation, (2005)
Service Activities:
- Institutional Service: Women in Medicine and Research, Roswell Park Cancer Institute, Co-Founder & Treasurer Women in Medicine and Research, Roswell Park Cancer Institute Co-‐Founder and Treasurer; Co-Founder (2013–present)
- Department/Medical School Service: Clinical Competency Committee, Hematology-Oncology Fellowship Clinical Competency Committee, UB/RPCI Hematology-‐Oncology Fellowship 1 of 4 faculty responsible for evaluating fellow evaluations 2x/year; Committee Member (2013–present)
- Department/Medical School Service: Associate Program Director, Hematology-Oncology Fellowship Associate Program Director, Hematology-‐Oncology Fellowship SUNY-‐UB School of Medicine and Roswell Park Cancer Institute, Buffalo, NY Primary responsibility for the Hematology Curriculum (malignant and benign) (2012–present)
- Editorial responsibilities: Associate Editor, Leukemia Research Reports journal Editorial responsibilities: Associate Editor, Leukemia Research Reports journal; Associate Editor (2012–present)
- Institutional Service: Distinguished Speaker Lecture Committee, Roswell Park Cancer Institute Distinguished Speaker Lecture Committee, Roswell Park Cancer Institute; Committee Member (2012–present)
- Cooperative Clinical Trials Group, Member, Alliance (formerly CALGB) Cooperative Cancer Center Group, Leukemia Core Committee, Leukemia Correlative Sc Cooperative Clinical Trials Group Member, Alliance (formerly CALGB) Cooperative Cancer Center Group Leukemia Core Committee Leukemia Correlative Sciences Committee; Member (2012–present)
- Peer Review: Abstract reviewer and oral session moderator, American Society of Hematology Annual meeting Abstract reviewer and oral session moderator American Society of Hematology Annual meeting; Peer Reviewer (2012–present)
- Institutional Service: Genomic Resource Advisory Committee, Roswell Park Cancer Institute Genomic Resource Advisory Committee, Roswell Park Cancer Institute; Committee Member (2010–2014)
- Institutional Service: Scientific Review Committee Scientific Review Committee Clinical Research Service, Roswell Park Cancer Institute; Committee Member (2009–2014)
- Service to the Public:Jacquie Hirsch for Acute Lymphocytic Leukemia (ALL) Foundation Jacquie Hirsch for Acute Lymphocytic Leukemia (ALL) Foundation Speaker at fundraising events (Tinkerball, Dancers Give Back) Researcher supported by foundation funds (2009–present)
- Institutional Service: Clinical Research Feasibility & Prioritization Committee, Roswell Park Cancer Institute Clinical Research Feasibility & Prioritization Committee Clinical Research Service, Roswell Park Cancer Institute; Committee Member (2009–present)
- National Panel Membership, NCCN - Acute Myeloid Leukemia Guidelines Panel National Panel Membership Member, National Comprehensive Cancer Network Acute Myeloid Leukemia Guidelines Panel; Member (2008–present)
- Institutional Service: Immunology Graduate Student Progress Committee, Roswell Park Cancer Institute Immunology Graduate Student Progress Committee, Roswell Park Cancer Institute; Committee Member (2007–2011)
- Institutional Serice: Co-‐Head, Immunology Graduate Student Journal Club, Roswell Park Cancer Institute Co-‐Head, Immunology Graduate Student Journal Club, Roswell Park Cancer Institute; Co-Chair (2007–2010)
- Instituional Service: Imaging Development Committee, Roswell Park Cancer Institute Imaging Development Committee, Roswell Park Cancer Institute; Committee Member (2007–2008)
- Department/Medical School Service: Faculty Interviewer, Hematology-Oncology Fellowship Faculty Interviewer, UB/RPCI Hematology-‐Oncology Fellowship 1 of 6 faculty responsible for interviewing fellow candidates (2007–present)
- Department/Medical School Service: Admissions Committee, Hematology-Oncology Fellowship Admissions Committee, UB/RPCI Hematology-‐Oncology Fellowship 1 of 3 faculty responsible for reviewing all applications; Committee Member (2007–present)
- Institutional Service: Member, Infection Control Committee, Roswell Park Cancer Institute Member, Infection Control Committee, Roswell Park Cancer Institute; Member (2006–2014)
- Service to the Public: Leukemia Lymphoma Society (Central/Western New York chapter) Service to the Public: Leukemia Lymphoma Society (Central/Western New York chapter) Provide annual patient education lecture in central and western New York areas (2006–present)
- Instituional Service: Member, Pharmacy and Therapeutics Committee, Roswell Park Cancer Institute Member, Pharmacy and Therapeutics Committee Roswell Park Cancer Institute; Member (2004–2006)
- Ad Hoc Manuscript Reviewer for the Following Journals Blood; Journal of Clinical Oncology; Clnical Cancer Reearch; Expert Opinion in Investigational Drugs; Genes Chromosomes and Cancer; American Journal of Hematology; Leukemia and Lymphoma; Oncology; British J. Haematology; Cancer Chemotherapy and Pharmacology; Chemistry and Laboratory Medicine; Leukemia Research; J Natonal Comprehensive Cancer Network; Plos One; Genome Medicine;; Ad Hoc Reviewer (2003–present)